EDIT:NASDAQ
Editas Medicine Inc
1,86 $
arrow_downward
-0,27%(-0,0050) 1D
17 նոյ, 10:36:20 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
287,07 մլն
Avg. vol.
2,41 մլն
Volume
245,52 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
287,07 մլն
Avg. vol.
2,41 մլն
Volume
245,52 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
TradingView
·
1 ժամ առաջ
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 ժամ առաջ
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
38 րոպե առաջ
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
1 ժամ առաջ
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc